Maruti Suzuki India has signed a five-year agreement with Kamarajar Port for export of its passenger vehicles to international markets. Under the agreement starting December 2022, Kamarajar Port will be used for exports to Africa, Middle East, Latin America, ASEAN, Oceania and SAARC regions by the company.
RailTel Corporation of India has bagged the work order from Webel Technology for acting as System Integrator for Capacity Enhancement of West Bengal State Data Centre (WB-SDC), Monibhandar, Kolkata. The total value of the work is Rs 98.56 crore (including GST).
Greaves Electric Mobility (GEMPL), the e-mobility business of Greaves Cotton, has adopted the Siemens Xcelerator portfolio of software and services to design, and develop its electric two & threewheeler vehicles for the Indian market. The initiative re-affirms Greaves’ vision to popularize EV adoption and bring affordable, sustainable, last mile mobility to India’s rapidly burgeoning EV ecosystem.
Mahindra Lifespace Developers has completed the acquisition of a 9.24-acre land parcel in Mumbai from Mahindra & Mahindra for Rs 365 crore. In February this year, Mahindra Lifespace had announced that it would purchase the land in Kandivali, Mumbai from Mahindra & Mahindra Ltd for the development of a housing project.
Rail Vikas Nigam (RVNL) has been awarded contract for Construction of Bhesan Depot cum Workshop which includes DDC, BCC and associated E&M works under Corridor- C2, Bhesan to Saroli, for Surat Metro Rail Project Phase- 1, DC 2 by Gujarat Metro Rail Corporation (GMRC). The total awarded cost of project is Rs 198.93 crore (Excluding taxes, duties and Provisional Sum).
Spandana Sphoorty Financial has raised Rs 65 crore through allotment of 650 Secured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs) having face value of Rs 10,00,000 each, at par, on a private placement basis in demat form. The Management Committee of the Board of Directors of the Company vide its resolution dated December 22, 2022, has approved and allotted the same.
Lupin Pharmaceuticals Inc., the U.S. based wholly-owned subsidiary of Lupin, is voluntarily recalling four lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril, observed in recent testing above the Acceptable Daily Intake (ADI) level. To date, Lupin has received no reports of illness that appear to relate to this issue. Lupin discontinued the marketing of Quinapril tablets in September 2022.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1470.45 |
| Dr. Reddys Lab | 5973.00 |
| Cipla | 1547.95 |
| Zydus Lifesciences | 1090.00 |
| Lupin | 1555.10 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
